Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interdigitating Oxaliplatin, 5-FU and Radiation in Metastatic Rectal Cancer
NCT00422864Phase 2Completed
- Sponsor
- Peter MacCallum Cancer Centre
- Start
- Oct 2006
- Primary completion
- Jun 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in rectal cancer, sponsored by Peter MacCallum Cancer Centre. Started Oct 2006; status: completed.
02
Drugs
oxaliplatin
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00422864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00422864.